Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muriel Stoppe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Neurology|August 9, 2017
Outcome of MS relapses in the era of disease-modifying therapyMuriel Stoppe, Maria Busch, Luise Krizek, et al.
Psychoneuroendocrinology|September 24, 2019
Hyperstable arousal regulation in multiple sclerosisMuriel Stoppe, Klara Meyer, Maike Schlingmann, et al.
International Journal of Molecular Sciences|August 29, 2024
Mineralocorticoid Receptor Signaling in Peripheral Blood Cells in Patients with Multiple SclerosisFranziska Küstermann, Kathy Busse, Johannes Orthgieß, et al.
Neural Plasticity|April 1, 2021
Motor Sequence Learning across Multiple Sessions Is Not Facilitated by Targeting Consolidation with Posttraining tDCS in Patients with Progressive Multiple SclerosisHarald Seelmann-Eggebert, Muriel Stoppe, Florian Then Bergh, et al.
Journal of Neurology|August 8, 2018
Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosisJost-Julian Rumpf, Sophie Dietrich, Muriel Stoppe, et al.
Journal of Neurology|March 19, 2014
Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasisMuriel Stoppe, Eva Thomä, Uwe Gerd Liebert, et al.
Scientific Reports|September 5, 2020
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patientsElisa Schmidt, Christian Schinke, Michael Rullmann, et al.
Psychoneuroendocrinology|February 8, 2017
Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesityChristian Schinke, Swen Hesse, Muriel Stoppe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2020
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from GermanyTania Kümpfel, Sandra Thiel, Ingrid Meinl, et al.
Stress (Amsterdam, Netherlands)|October 30, 2018
Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controlsChristian Schinke, Swen Hesse, Michael Rullmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Neurology|August 9, 2017
Outcome of MS relapses in the era of disease-modifying therapyMuriel Stoppe, Maria Busch, Luise Krizek, et al.
Psychoneuroendocrinology|September 24, 2019
Hyperstable arousal regulation in multiple sclerosisMuriel Stoppe, Klara Meyer, Maike Schlingmann, et al.
International Journal of Molecular Sciences|August 29, 2024
Mineralocorticoid Receptor Signaling in Peripheral Blood Cells in Patients with Multiple SclerosisFranziska Küstermann, Kathy Busse, Johannes Orthgieß, et al.
Neural Plasticity|April 1, 2021
Motor Sequence Learning across Multiple Sessions Is Not Facilitated by Targeting Consolidation with Posttraining tDCS in Patients with Progressive Multiple SclerosisHarald Seelmann-Eggebert, Muriel Stoppe, Florian Then Bergh, et al.
Journal of Neurology|August 8, 2018
Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosisJost-Julian Rumpf, Sophie Dietrich, Muriel Stoppe, et al.
Journal of Neurology|March 19, 2014
Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasisMuriel Stoppe, Eva Thomä, Uwe Gerd Liebert, et al.
Scientific Reports|September 5, 2020
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patientsElisa Schmidt, Christian Schinke, Michael Rullmann, et al.
Psychoneuroendocrinology|February 8, 2017
Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesityChristian Schinke, Swen Hesse, Muriel Stoppe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2020
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from GermanyTania Kümpfel, Sandra Thiel, Ingrid Meinl, et al.
Stress (Amsterdam, Netherlands)|October 30, 2018
Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controlsChristian Schinke, Swen Hesse, Michael Rullmann, et al.
Pageof 2